Rafarma Pharmaceuticals Inc (RAFA)
0.102
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 8.554M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -70.09% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 95.77% |
Profile
Rafarma Pharmaceuticals Inc is engaged in pharmaceuticals and has several subsidiaries specializing in developing and producing medical equipment, as well as supplying equipment for hospitals and clinics from Germany, China, Slovakia, and others. |
URL | https://www.rafarma.si |
Investor Relations URL | N/A |
HQ State/Province | Utah |
Sector | |
Industry | |
Equity Style | N/A |
Next Earnings Release | May. 17, 2024 (est.) |
Last Earnings Release | Nov. 11, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Rafarma Pharmaceuticals Inc is engaged in pharmaceuticals and has several subsidiaries specializing in developing and producing medical equipment, as well as supplying equipment for hospitals and clinics from Germany, China, Slovakia, and others. |
URL | https://www.rafarma.si |
Investor Relations URL | N/A |
HQ State/Province | Utah |
Sector | |
Industry | |
Equity Style | N/A |
Next Earnings Release | May. 17, 2024 (est.) |
Last Earnings Release | Nov. 11, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |